1 / 20

Multimodal analgesia A brief summary

This brief summary by Daniel Nash, CRNA, DNAP covers the basic goals and target sites of multimodal therapies, including pharmacologic and non-pharmacologic approaches. Learn about medications, non-pharmacological therapies, and multimodal targets to enhance pain management. Explore the goals of multimodal analgesia and ways to prevent opioid complications.

awhitehead
Download Presentation

Multimodal analgesia A brief summary

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Multimodal analgesia A brief summary Daniel Nash CRNA DNAP

  2. Objectives • Name basic goals of multimodal therapies • Discuss target sites of multimodal therapies • Pharmacologic and non-pharmacologic • Discuss medications for multimodal therapy and learn their site of action.

  3. Goals of multimodal analgesia • Block nociceptive transmission along multiple targets along the pain pathway. • Preventative in nature – stop before it starts • Augment bodies natural pain inhibition pathways • Reduce stress response • Reduce opioid complications

  4. Non-pharmacological therapy • Ice and elevation • Hypnosis, imagery, acupuncture • Music therapy – headphones in surgery • TENS units • Cognitive behavioral therapy

  5. Multimodal targets • Mediators of pain/inflammation • Thromboxane and prostaglandins • Voltage gated Na+ channels- peripheral nerve blocks • Neurotransmitter sites • Opioid receptors • NDMA receptors • Alpha 2 receptors • Presynaptic voltage gated Ca++ channels • Cannabinoid receptors • Vanniloids (TRPV-1) Capsaicin • Seritonergic and antidepressants

  6. NSAIDS • COX 1 & 2 • Aspirin • Acetominophen- Ofirmev • Toradol, Indocin, Ibuprofen, Naprosyn • Cox 2 • Celebrex (Vioxx and Bextra off market)

  7. NDMA antagonists Ketamine Magnesium

  8. Neuroplasticity

  9. Magnesium infusion

  10. Fraudulent initial research but accurate results! Multimodal has since been verified as effective through many well designed outcome based research studies.

More Related